Literature DB >> 10968427

Vasopeptidase inhibition and angio-oedema.

F H Messerli1, J Nussberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10968427     DOI： 10.1016/S0140-6736(00)02596-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  40 in total

Review 1.  Heart failure in 10 years time: focus on pharmacological treatment.

Authors:  J J V McMurray
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

2.  Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats.

Authors:  Lodi C W Roksnoer; Richard van Veghel; René de Vries; Ingrid M Garrelds; Usha M Bhaggoe; Edith C H Friesema; Frank P J Leijten; Marko Poglitsch; Oliver Domenig; Marian C Clahsen-van Groningen; Ewout J Hoorn; A H Jan Danser; Wendy W Batenburg
Journal:  Kidney Int       Date:  2015-04-01       Impact factor: 10.612

3.  Imidapril: will fewer adverse events translate into better long-term outcomes?

Authors:  Tom Richart; Jan A Staessen; Willem H Birkenhäger
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  ACE Inhibitor-Induced Angioedema: a Review.

Authors:  William J Kostis; Mrinali Shetty; Yuvraj Singh Chowdhury; John B Kostis
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

5.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2001-10

6.  The Mechanism of Action of LCZ696.

Authors:  Juan Tamargo Menendez
Journal:  Card Fail Rev       Date:  2016-05

Review 7.  [Drug-induced angioedema : Focus on bradykinin].

Authors:  B Sachs; T Meier; M M Nöthen; C Stieber; J Stingl
Journal:  Hautarzt       Date:  2018-04       Impact factor: 0.751

8.  Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

Authors:  Frank T Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

9.  Recent clinical trials with omapatrilat: new developments.

Authors:  Anne Zanchi; Marc Maillard; Michel Burnier
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

10.  ACE-I induced angioedema: a case report and review of literature.

Authors:  Philip Babatunde Adebayo; Olutayo Christopher Alebiosu
Journal:  Cases J       Date:  2009-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.